| # | Drug | Count |
|---|---|---|
| 0 | SOMATROPIN | 129 |
| 1 | PERFLUOROHEXYLOCTANE | 73 |
| 2 | ABATACEPT | 48 |
| 3 | ALBUTEROL SULFATE | 31 |
| 4 | ETANERCEPT | 31 |
| 5 | ETONOGESTREL | 20 |
| 6 | ORAL SEMAGLUTIDE | 17 |
| 7 | OMALIZUMAB | 16 |
| 8 | ALBUTEROL | 15 |
| 9 | LIFITEGRAST | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PERFLUOROHEXYLOCTANE | 73 | 0.0314 |
| 1 | CANTHARIDIN | 1 | 0.0055 |
| 2 | FLUOROMETHOLONE ACETATE | 1 | 0.0037 |
| 3 | ADALIMUMAB-ADBM | 1 | 0.0037 |
| 4 | TRIMIPRAMINE | 3 | 0.0027 |
| 5 | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | 1 | 0.0025 |
| 6 | CARBAMIDE PEROXIDE | 1 | 0.0023 |
| 7 | ALBUTEROL SULFATE AND BUDESONIDE | 3 | 0.0019 |
| 8 | ADALIMUMAB-ATTO | 3 | 0.0019 |
| 9 | SOMATROPIN | 129 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 205 |
| 1 | Semifluorinated Alkane [EPC] | 73 |
| 2 | Recombinant Human Growth Hormone [EPC] | 51 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 48 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 48 |
| 5 | GLP-1 Receptor Agonist [EPC] | 24 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 7 | Corticosteroid [EPC] | 23 |
| 8 | Progestin [EPC] | 20 |
| 9 | Anti-IgE [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Semifluorinated Alkane [EPC] | 73 | 0.0314 |
| 1 | PCSK9 Inhibitor [EPC] | 205 | 0.0080 |
| 2 | Recombinant Human Growth Hormone [EPC] | 51 | 0.0023 |
| 3 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 15 | 0.0009 |
| 4 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 5 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 48 | 0.0003 |
| 8 | Thymic Stromal Lymphopoietin Blocker [EPC] | 2 | 0.0003 |
| 9 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |